PLAT and COVID-19: The strategies of substituting the tissue plasminogen activator (tPA) [25,26] or proline (K986P, V987P) [27,28,29,30] for the spike protein have been applied to various COVID-19 vaccine candidates in an attempt to improve the efficiency of antigen expression.